
1. beta. 1999 apr;12(2):6.

major vaccine trials begin.

highleyman l.

aids: march 8 marked beginning first hiv vaccine effectiveness trial
in san francisco bay area, conducted san francisco department of
public health university california san francisco. phase iii
trial expected run four years 50 locations, enroll 5,000
participants u.s. study test recombinant vaccine known as
aidsvax b/b, developed vaxgen. similar trial enroll 2,500 injection
drug users thailand. related news, national institute allergy and
infectious diseases launched vaccine trial africa february. phase i
trial enroll 40 hiv-negative participants uganda test alvac, a
vaccine produced pasteur merieux connaught. contact information san
francisco bay area trial provided.

pmid: 11366701  [indexed medline]

